CalciMedica (CALC) Earnings Date & Reports

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CALC is expected to report earnings to rise 27.78% to -46 cents per share on May 10

Q1'23

Est.

$-0.46

Q1'25

Beat

by $1.11

Q4'24

Beat

by $0.65

Q4'22

Beat

by $0.08

Q3'22

Missed

by $0.05

The last earnings report on May 14 showed earnings per share of -36 cents, beating the estimate of -147 cents. With 59.07K shares outstanding, the current market capitalization sits at 19.98M.

View a ticker or compare two or three

Compare

CALC